Literature DB >> 9934759

Role of immunosuppressive therapy in refractory sprue-like disease.

P Rolny1, H A Sigurjonsdottir, H Remotti, L A Nilsson, H Ascher, H Tlaskalova-Hogenova, L Tuckova.   

Abstract

Patients with malabsorption and histological findings consistent with celiac disease, who are unresponsive to gluten free diet, and in whom other causes of flat mucosa have been excluded, are considered to suffer from so called unclassified or refractory sprue. Although the true nature of this condition needs to be further elucidated, it is known to represent a difficult therapeutical problem with potentially fatal course. Herein, we report a patient with refractory sprue-like disease who after failing to respond to corticosteroids and TPN was in a critical condition. He responded promptly to cyclosporine and made a remarkable recovery. In contrast to previous reports, the cyclosporine treatment in this patient was pursued only for 1 month, whereupon the patient turned responsive to steroids. Subsequent treatment with azathioprine allowed corticosteroids to be reduced to a low maintenance dose and eventually all drugs could be discontinued without reappearance of symptoms. Cyclosporine therapy might be lifesaving in occasional patients with refractory sprue-like disease and it may result in reversal of steroid resistance. Moreover, azathioprine seems to have a steroid sparing effect in this setting. Short term immunosuppressive treatment may have an advantage of lower risk for drug related side effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934759     DOI: 10.1111/j.1572-0241.1999.00799.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

Review 1.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

Review 2.  Adult-onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab.

Authors:  Jill E Elwing; Ray E Clouse
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

3.  A severe but reversible refractory sprue.

Authors:  X Dray; F Joly; A Lavergne-Slove; X Treton; Y Bouhnik; B Messing
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 4.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  Refractory celiac disease.

Authors:  Hani Abdallah; Daniel Leffler; Melinda Dennis; Ciarán P Kelly
Journal:  Curr Gastroenterol Rep       Date:  2007-10

6.  Wireless capsule endoscopy as a tool in diagnosing autoimmune enteropathy.

Authors:  Eva-Marie Gram-Kampmann; Søren T Lillevang; Sönke Detlefsen; Stig Borbjerg Laursen
Journal:  BMJ Case Rep       Date:  2015-07-06

7.  [Clinical features and diagnosis of celiac disease].

Authors:  J Stein
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

Review 8.  Autoimmune Enteropathy: An Updated Review with Special Focus on Stem Cell Transplant Therapy.

Authors:  Zunirah Ahmed; Aamer Imdad; James A Connelly; Sari Acra
Journal:  Dig Dis Sci       Date:  2018-11-10       Impact factor: 3.199

9.  Celiac Disease.

Authors:  Ahmad S. Abdulkarim; Joseph A. Murray
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

10.  The management of refractory coeliac disease.

Authors:  Jeremy Woodward
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.